Literature DB >> 28930531

Isolongifolene attenuates rotenone-induced mitochondrial dysfunction, oxidative stress and apoptosis.

Rengasamy Balakrishnan1, Namasivayam Elangovan2, Thangavel Mohankumar1, Jegadeesan Nataraj3, Thamilarasan Manivasagam3, Arokiasamy Justin Thenmozhi4, Mohamed Musthafa Essa5, Mohammed Akbar6, Mohammed Abdul Sattar Khan7.   

Abstract

The present study was carried out to investigate the neuroprotective effects of isolongifolene (ILF), a tricyclic sesquiterpene of Murraya koenigii, against rotenone-induced mitochondrial dysfunction, oxidative stress and apoptosis in a cellular model. SH-SY5Y human neuroblastoma cells were divided into four experimental groups (control, rotenone (100 nM), ILF (10 microM) + rotenone (100 nanoM), ILF 10 microM alone treated) based on 3-(4, 5-dimethyl 2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. The results of the present study showed that the ILF treatment significantly alleviated rotenone-induced cytotoxicity, oxidative stress and mitochondrial dysfunction in SH-SY5Y cells. Moreover, ILF attenuated rotenone induced toxicity by down-regulating  Bax, caspases-3, 6, 8 and 9 expression and up-regulating of Bcl-2 expression. Furthermore regulation of p-P13K, p-AKT and p-GSK-3 beta expression by ILF, clearly confirmed its protective effects. Taken together, our results suggested that ILF attenuated rotenone-induced oxidative stress, mitochondrial dysfunction and apoptosis through the regulation of P13K/AKT/GSK-3 beta signaling pathways. However further pre-clinical studies are warranted in rodents to use ILF as a promising therapeutic agent for PD in future.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28930531     DOI: 10.2741/s513

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  3 in total

1.  Repeatedly heated mix vegetable oils-induced atherosclerosis and effects of Murraya koenigii.

Authors:  Gul Ambreen; Afshan Siddiq; Kashif Hussain; Abdul Saboor Hussain; Zara Naz
Journal:  BMC Complement Med Ther       Date:  2020-07-14

Review 2.  Medicinal Profile, Phytochemistry, and Pharmacological Activities of Murraya koenigii and its Primary Bioactive Compounds.

Authors:  Rengasamy Balakrishnan; Dhanraj Vijayraja; Song-Hee Jo; Palanivel Ganesan; In Su-Kim; Dong-Kug Choi
Journal:  Antioxidants (Basel)       Date:  2020-01-24

Review 3.  Multi-Target Approach of Murraya koenigii Leaves in Treating Neurodegenerative Diseases.

Authors:  Mario A Tan; Niti Sharma; Seong Soo A An
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.